Joyce Lee
Professor of Medicine UCDHSC
Dr. Joyce Lee is Professor of Pulmonary Sciences and Critical Care Medicine and Director of the Interstitial Lung Disease Program at the University of Colorado School of Medicine. Her research focuses on advancing clinical and translational understanding of scarring lung diseases, including IPF and connective tissue-associated ILD. She leads studies on risk factors, biomarkers, genetics, and quality of life for patients and caregivers. Dr. Lee established the University’s ILD program, now part of the PFF Care Center Network, and leads multiple NIH and investigator-initiated clinical trials.
Seminars
With new therapies on the horizon, the IPF treatment landscape is evolving. This panel brings together leading clinicians and academics to explore how emerging drugs will fit into current treatment paradigms. Experts will discuss the clinical decision-making process for first-line therapy, balancing efficacy, safety, and patient-specific factors.
While genetic predisposition plays a role in IPF, not all individuals with risk factors develop the disease. Understanding both susceptibility and resilience can provide critical insights into early detection and potential therapeutic strategies. This workshop will explore the latest advancements in genetics, familial risk factors, and emerging research on protective mechanisms that could inform new treatment approaches.
Get ready to explore:
Understanding Resiliency: Why Do Some Individuals Avoid IPF Despite Risk Factors?
- Exploring why some high-risk individuals never develop lung disease
- Identifying protective biological mechanisms that could inform new therapies
- Reviewing emerging research on cellular and molecular markers of resilience
Genetics & Familial Risk Factors: Improving Early Detection
- Investigating hereditary risk factors and genetic polymorphisms in IPF
- Leveraging familial studies and at-risk cohort screenings for early diagnosis
- Exploring predictive modeling and polygenic risk scores Beyond Known Genetics: Novel Research & Therapeutic Targets
- Examining new genetic discoveries beyond well-known mutations
- Understanding gene-environment interactions and epigenetics in IPF
- Exploring industry efforts in gene-targeted therapies and prevention
